Welcome! If you have a coupon code, click here to apply it. Apply
stock
Y mAbs Therapeutics
NASDAQ | YMAB
4.96
USD
0.00 ( 0.00%)
AT CLOSE (AS OF Jun 25, 2025)
$232M
MARKET CAP
-
P/E Ratio
-0.64
EPS
$16
52 Week High
$3.6
52 Week Low
LIFE SCIENCES
Sector
YMAB Chart
Recent Chart
Price Action
1D
Candles
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
YMAB Technicals
YMAB Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $72M |
| Total Revenue | $88M |
| Cost Of Revenue | $15M |
| Costof Goods And Services Sold | $15M |
| Operating Income | -$31M |
| Selling General And Administrative | $55M |
| Research And Development | $49M |
| Operating Expenses | $104M |
| Investment Income Net | - |
| Net Interest Income | $1.4M |
| Interest Income | $1.4M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $535K |
| Income Before Tax | -$30M |
| Income Tax Expense | -$146K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$30M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$31M |
| Ebitda | -$31M |
| Net Income | -$30M |
Revenue & Profitability
Earnings Performance
YMAB Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $120M |
| Total Current Assets | $99M |
| Cash And Cash Equivalents At Carrying Value | $67M |
| Cash And Short Term Investments | $67M |
| Inventory | $7.2M |
| Current Net Receivables | $20M |
| Total Non Current Assets | $21M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $2.3M |
| Intangible Assets Excluding Goodwill | $2.3M |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $4.4M |
| Other Non Current Assets | - |
| Total Liabilities | $28M |
| Total Current Liabilities | $24M |
| Current Accounts Payable | $6.7M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $630K |
| Total Non Current Liabilities | $4.2M |
| Capital Lease Obligations | $820K |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $820K |
| Other Current Liabilities | $16M |
| Other Non Current Liabilities | $812K |
| Total Shareholder Equity | $92M |
| Treasury Stock | - |
| Retained Earnings | -$487M |
| Common Stock | $4K |
| Common Stock Shares Outstanding | $44M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$16M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $535K |
| Capital Expenditures | $0 |
| Change In Receivables | - |
| Change In Inventory | -$2.1M |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | $4.3M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$30M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $72M |
| Total Revenue | $88M |
| Cost Of Revenue | $15M |
| Costof Goods And Services Sold | $15M |
| Operating Income | -$31M |
| Selling General And Administrative | $55M |
| Research And Development | $49M |
| Operating Expenses | $104M |
| Investment Income Net | - |
| Net Interest Income | $1.4M |
| Interest Income | $1.4M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $535K |
| Income Before Tax | -$30M |
| Income Tax Expense | -$146K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$30M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$31M |
| Ebitda | -$31M |
| Net Income | -$30M |
YMAB News
YMAB Profile
Y mAbs Therapeutics Profile
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of new antibody-based therapeutics for the treatment of cancer in the United States. The company is headquartered in New York, New York.
PSTV 67.06%
$0.3124
ICU 16.46%
$0.4188
GNLN -19.10%
$0.0072
HCTI -5.15%
$0.0313
NVDA 3.91%
$153.6818
QS 28.06%
$5.545
DNN -3.33%
$1.74
LCID -0.92%
$2.15
VOR 51.59%
$0.4822
TSLA -4.42%
$325.42
SRFM 10.99%
$3.9955
SONM 7.59%
$1.205
AXDX -61.36%
$0.034
VHAI -25.00%
$0.0004
F -2.28%
$10.4851
SMCI 8.19%
$46.35
AMD 3.26%
$142.94
ABEV -3.15%
$2.3243
SAFX
58.54%
$2.711
LYT -16.78%
$0.0982
BB 14.09%
$4.9399
JWN 0.08%
$24.66
BLNE -4.15%
$1.361
SOFI 1.04%
$16.0147
HIMS -0.88%
$42.57
INTC -1.80%
$22.145
PLTR -0.25%
$142.8688
CRCL
-8.08%
$204.665
WULF 0.91%
$3.875
PLUG -4.31%
$1.11
ONDS 3.77%
$1.65
DFS -0.21%
$200.05
BTE 0.26%
$1.8147
QXO -6.09%
$22.0771
CUTR -10.19%
$0.0969
HOOD 1.16%
$82.9582
RIG -2.04%
$2.645
WBD -0.02%
$10.898
NCNA -3.98%
$0.0869
NVTS -0.88%
$7.285
RIOT -1.15%
$9.905
MARA 0.84%
$15.005
VALE -1.51%
$9.0712
APLD -3.73%
$9.935
ACHR -5.36%
$10.155
AAPL 0.30%
$200.9109
CLSK 5.83%
$10.625
AAL -3.42%
$10.9807
GRAB -2.13%
$4.6388
SOUN -0.97%
$9.725
CAN -5.27%
$0.6153
BTG 0.84%
$3.59
GOOGL 1.84%
$169.845
COIN 1.53%
$350.091
AFMD -34.95%
$0.1815
WLGS 5.17%
$0.0509
NAAS 12.81%
$0.8664
ITUB -3.09%
$6.58
LDTC -19.74%
$0.1525
TMC 15.39%
$7.6271
GCTK 37.52%
$8.54
RZLV 5.56%
$2.9346
STLA 2.76%
$9.855
NKTR 31.70%
$32.2
ULY 77.03%
$7.9499
QBTS -1.86%
$14.6918
SHEL -0.85%
$69.545
RGTI 0.83%
$11.595
IREN 4.49%
$12.058
AG 1.13%
$8.1507
QSI 11.44%
$2.095
GNS 12.25%
$0.7824
AMZN -0.66%
$211.37
ADIL 7.02%
$0.2454
BBD -0.99%
$3
MLGO 5.22%
$0.6104
SNAP -3.31%
$8.045
KEY 1.58%
$16.75
MU -0.82%
$126.865
CIFR -0.51%
$3.8304
NIO -0.86%
$3.47
ASTS -5.56%
$50.26
BAC 0.63%
$46.9531
MULN -11.30%
$0.8959
CCL -1.51%
$25.3128
GOOG 1.88%
$170.89
RXRX -2.01%
$5.115
IBO 16.80%
$0.9811
EQX 1.48%
$5.916
PBR -0.93%
$12.2952
RKLB -3.02%
$32.45
IQ -3.37%
$1.72
NGD 0.55%
$4.8767
HL 0.26%
$5.815
PCG -1.66%
$13.925
PTN -44.65%
$0.0941
SBET 10.46%
$10.67
PFE -0.12%
$24.2802
FLG -4.41%
$10.63
ZAPP -46.31%
$0.1548
PSTV 67.06%
$0.3124
ICU 16.46%
$0.4188
GNLN -19.10%
$0.0072
HCTI -5.15%
$0.0313
NVDA 3.91%
$153.6818
QS 28.06%
$5.545
DNN -3.33%
$1.74
LCID -0.92%
$2.15
VOR 51.59%
$0.4822
TSLA -4.42%
$325.42
SRFM 10.99%
$3.9955
SONM 7.59%
$1.205
AXDX -61.36%
$0.034
VHAI -25.00%
$0.0004
F -2.28%
$10.4851
SMCI 8.19%
$46.35
AMD 3.26%
$142.94
ABEV -3.15%
$2.3243
SAFX
58.54%
$2.711
LYT -16.78%
$0.0982
BB 14.09%
$4.9399
JWN 0.08%
$24.66
BLNE -4.15%
$1.361
SOFI 1.04%
$16.0147
HIMS -0.88%
$42.57
INTC -1.80%
$22.145
PLTR -0.25%
$142.8688
CRCL
-8.08%
$204.665
WULF 0.91%
$3.875
PLUG -4.31%
$1.11
ONDS 3.77%
$1.65
DFS -0.21%
$200.05
BTE 0.26%
$1.8147
QXO -6.09%
$22.0771
CUTR -10.19%
$0.0969
HOOD 1.16%
$82.9582
RIG -2.04%
$2.645
WBD -0.02%
$10.898
NCNA -3.98%
$0.0869
NVTS -0.88%
$7.285
RIOT -1.15%
$9.905
MARA 0.84%
$15.005
VALE -1.51%
$9.0712
APLD -3.73%
$9.935
ACHR -5.36%
$10.155
AAPL 0.30%
$200.9109
CLSK 5.83%
$10.625
AAL -3.42%
$10.9807
GRAB -2.13%
$4.6388
SOUN -0.97%
$9.725
CAN -5.27%
$0.6153
BTG 0.84%
$3.59
GOOGL 1.84%
$169.845
COIN 1.53%
$350.091
AFMD -34.95%
$0.1815
WLGS 5.17%
$0.0509
NAAS 12.81%
$0.8664
ITUB -3.09%
$6.58
LDTC -19.74%
$0.1525
TMC 15.39%
$7.6271
GCTK 37.52%
$8.54
RZLV 5.56%
$2.9346
STLA 2.76%
$9.855
NKTR 31.70%
$32.2
ULY 77.03%
$7.9499
QBTS -1.86%
$14.6918
SHEL -0.85%
$69.545
RGTI 0.83%
$11.595
IREN 4.49%
$12.058
AG 1.13%
$8.1507
QSI 11.44%
$2.095
GNS 12.25%
$0.7824
AMZN -0.66%
$211.37
ADIL 7.02%
$0.2454
BBD -0.99%
$3
MLGO 5.22%
$0.6104
SNAP -3.31%
$8.045
KEY 1.58%
$16.75
MU -0.82%
$126.865
CIFR -0.51%
$3.8304
NIO -0.86%
$3.47
ASTS -5.56%
$50.26
BAC 0.63%
$46.9531
MULN -11.30%
$0.8959
CCL -1.51%
$25.3128
GOOG 1.88%
$170.89
RXRX -2.01%
$5.115
IBO 16.80%
$0.9811
EQX 1.48%
$5.916
PBR -0.93%
$12.2952
RKLB -3.02%
$32.45
IQ -3.37%
$1.72
NGD 0.55%
$4.8767
HL 0.26%
$5.815
PCG -1.66%
$13.925
PTN -44.65%
$0.0941
SBET 10.46%
$10.67
PFE -0.12%
$24.2802
FLG -4.41%
$10.63
ZAPP -46.31%
$0.1548
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.